Fibroepithelial polyp of the anus

Summary

Fibroepithelial polyp of the anus (MONDO:0006549) is a disease. A subtype of fibroepithelial polyp — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

Field	Value
Canonical name	fibroepithelial polyp of the anus
Mondo ID	MONDO:0006549
EFO	EFO:1000699
DOID	DOID:8170
NCIT	C4435
SNOMED CT	195469007
UMLS	C0345903
MedGen	87519
Anatomy (UBERON)	UBERON:0001245
Is cancer (heuristic)	no

Also known as: anal fibroepithelial polyp · anal fibrous polyp · anal tag · anus skin tag · fibroepithelial polyp of anus · fibrous polyp of anus · fibrous polyp of the anus

Disease family

This is a subtype of fibroepithelial polyp. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by etiologic mechanism › cancer or benign tumor › polyp › fibroepithelial polyp › fibroepithelial polyp of the anus

Related subtypes (6): skin tag, fibroepithelial polyp of urethra, vulva fibroepithelial polyp, gingival fibroepithelial polyp, vaginal fibroepithelial polyp, cervical fibroepithelial polyp

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 0.